Skip to Main Content

Advertisement

Skip Nav Destination

Aaron Gerds, MD: Glasdegib and New Directions in Myelofibrosis Treatment

December 30, 2021
On location

Dr. Gerds discusses results from an ongoing trial of glasdegib, a novel hedgehog inhibitor, in patients with heavily pretreated myelofibrosis and significant disease burden.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X